• Disclosure
  • Privacy Policy
  • DMCA Policy
  • CCPA
  • Medical Disclaimer
Thursday, March 30, 2023
McLennan County News
  • Home
  • News
  • Business
  • Technology
    • Crytpocurrency
    • Gaming
    • Gadgets
  • Sports
  • Health
  • General
    • Business Services
  • Travel
  • Press Releases
  • Popular
No Result
View All Result
  • Home
  • News
  • Business
  • Technology
    • Crytpocurrency
    • Gaming
    • Gadgets
  • Sports
  • Health
  • General
    • Business Services
  • Travel
  • Press Releases
  • Popular
No Result
View All Result
No Result
View All Result
Home Technology Gaming

Stocks In The News: Tata Motors, Tech Mahindra, SBI, Lupin And IB Housing – Economic Times

stocks-in-the-news:-tata-motors,-tech-mahindra,-sbi,-lupin-and-ib-housing-–-economic-times
Share on FacebookShare on Twitter

Nifty futures on the Singapore Exchange traded 28.5 points, or 0.17 per cent higher at 17,263.50, signaling that Dalal Street was headed for a positive start on Monday. Here are a dozen stocks which may buzz the most in today’s trade:

Tata Motors: With input costs continuing to rise, automaker like Tata Motors are looking to increase vehicle prices from January next year to offset the impact. Already, car market leader Maruti Suzuki has announced to hike vehicle prices from next month.

State : The largest PSU lender has invited bids from asset reconstruction companies, and other financial institutions to sell an NPA account KSK Mahanadi Power Company, with total outstanding against the company standing over Rs 4,100 crore.

Tech Mahindra: The IT major said it has acquired 100 per cent stake in Activus Connect, which provides work-at-home customer experience management solutions, for $62 million (about Rs 466 crore). The US based Activus Connect has 1,750 employees and reported a revenue of USD 17 million in the financial year ended December 31, 2020.

Lupin: The drug maker said it has inked a marketing pact with Biomm SA to distribute and market biosimilar Pegfilgrastim in Brazil. The company has entered into an exclusive distribution and marketing agreement with Biomm SA in Brazil for distribution of Pegfilgrastim.

Macrotech Developers: The structure of Indian real estate is improving in a meaningful way with disciplined supply and consumers demand gravitating towards branded developers having better execution track record.

Aurobindo Pharma, Unichem Laboratories: The pharma players are recalling different products in the US market, the world’s largest market for medicines, due to manufacturing issues. As per the latest enforcement report issued by the USFDA, Aurobindo’s US-based unit is recalling 7,296 containers of hypertension drug Carvedilol tablets.

Indiabulls Housing Finance: The NBFC said it will raise up to Rs 1,000 crore through a public issue of bonds that opens next week. The base issue size of the bonds, in the nature of secured redeemable NCDs, is of Rs 200 crore with an option to retain oversubscription up to Rs 800 crore, aggregating up to Rs 1,000 crore.

Narayana Hrudayalaya: The healthcare provider has joined hands with Ritesh Properties to set up a 225-bed multi-specialty hospital in Ludhiana, Punjab. The hospital would come up at the Ludhiana-Chandigarh highway. Spread over 2 lakh square feet, the the hospital is expected to be operational by 2024.

RSWM: The group company of the LNJ Bhilwara is foraying into knitted fabric in line with the demand trend which will contribute Rs 800 crore to its topline over the next two to three years, a senior company official said.

Petrochemicals: The chemical player said it has received board approval to acquire compulsory convertible debentures worth up to Rs 1,000 crore issued by its subsidiary

Mangalore Petrochemicals Limited (OMPL).

Dish TV: The direct-to-Home service provider, which is facing a notice from its largest shareholder Yes Bank to reconstitute its board, has said it would convene its Annual General Meeting on December 30.

had postponed its AGM for a month after getting regulatory approval from the Registrar of Companies, Mumbai.

Morepen Laboratories: The drug firm said it has received approval from the US health regulator to market its generic anti-allergy drug in the American market. The company sells the product in India under the Fexopen brand (Fexofinadine Hydrochloride). Morepen’s product is the generic version of Sanofi Aventis’ anti-allergy drug Allegra.

Eris Lifesciences: The Drug maker said it has formed a joint venture with Mumbai-based MJ Biopharm to enter the insulin segment. Eris MJ Biopharm, the 70:30 joint venture (with Eris holding a 70 per cent stake), would primarily engage in marketing and distribution of human and analogue insulin including Aspart, Glargine.



Karda Constructions:
French financial services company Societe Generale acquired 36 lakh equity shares in Karda Constructions (0.58 percent) at Rs 16.65 per share via an open market transaction on the NSE as per the bulk deals data.



Kirloskar Oil Engines:
Nalanda India, the Indian investment arm of a Singapore-based investment firm, has made a partial exit from its 13-year-old listed portfolio company Kirloskar Oil Engines as it sold 5.2 million shares at Rs 180.9 apiece through two bulk deals on the National Stock Exchange.



Krishna Institute of Medical Science:
The recently listed healthcare services player was in the buzz as Malabar Select Fund offloaded more than 4 lakh equity shares of the company at Rs 1,319.04 apeice, the NSE bulk deal data showed.



Teamlease Services:
The special consumer services player has sold its 100 per cent share holding in IITJ education.

(What’s moving Sensex and Nifty Track latest market news, stock tips and expert advice on ETMarkets. Also, ETMarkets.com is now on Telegram. For fastest news alerts on financial markets, investment strategies and stocks alerts, subscribe to our Telegram feeds.)

Download The Economic Times News App to get Daily Market Updates & Live Business News.

McLennan County News

© 2021 McLennan County News Online

Navigate Site

  • Disclosure
  • Privacy Policy
  • DMCA Policy
  • CCPA
  • Medical Disclaimer

Follow Us

No Result
View All Result
  • Home
  • DMCA Policy
  • Medical Disclaimer
  • Privacy Policy
  • Disclosure
  • CCPA
  • Terms of Use

© 2021 McLennan County News Online

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept All”, you consent to the use of ALL the cookies. However, you may visit "Cookie Settings" to provide a controlled consent.
Cookie SettingsAccept All
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
SAVE & ACCEPT